Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Delapril Hydrochloride

The hydrochloride salt of delapril, a lipophilic, non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
OBJECTIVE The objective of the study was to assess potential pharmacokinetic interactions between delapril, an angiotensin… Expand
2003
2003
Long-term treatment with an angiotensin II type 1 receptor blocker (ARB) has been shown to decrease the plasma renin activity… Expand
2003
2003
OBJECTIVES The aim of the present study was to compare the pharmacokinetic and pharmacodynamic properties of a fixed combination… Expand
2000
2000
Thirty-nine hypertensive patients with type 2 diabetes mellitus were followed under long-term treatment (mean, 20.7 months) with… Expand
1998
1998
The long-term effect of delapril hydrochloride, a non-sulfhydryl angiotensin converting enzyme inhibitor, on serum concentrations… Expand
1994
1994
Abstract— An oral controlled‐release drug delivery system based on microspheres of polyglycerol esters of fatty acids (PGEFs… Expand
1992
1992
To study the effect of antihypertensive therapy on the regulation of renin gene expression, the levels of tissue renin messenger… Expand
1991
1991
Previously we reported that immunoreactive angiotensin II (Ang II) release from isolated perfused human umbilical veins was… Expand
1990
1990
The effect of the newly developed angiotensin-converting enzyme (ACE) inhibitor, delapril hydrochrolide (CV-3317), on the release… Expand
1987
1987
The acute effect on the renin-angiotensin system and the pharmacokinetic properties of delapril, a new angiotensin converting… Expand